Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Agnar** is an oral fixed-dose bone-health nutritional supplement marketed by Getz Pharma. Each film-coated tablet supplies elemental calcium 500 mg, cholecalciferol 400 IU, and menaquinone-7 90 mcg. It is used to help prevent or treat calcium, vitamin D, and vitamin K deficiency-related bone conditions, including osteoporosis, osteomalacia, rickets, and hypoparathyroidism. Calcium supports bone mineralization, cholecalciferol promotes calcium and phosphate absorption after metabolic activation, and vitamin K2 supports vitamin K-dependent activation of proteins involved in bone health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium + cholecalciferol + menaquinone-7.